CNWT yields 222222.22% · PFE yields 6.13%● Live data
📍 CNWT pulled ahead of the other in Year 1
Combined, CNWT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CNWT + PFE for your $10,000?
Cistera Networks, Inc. provides enterprise and small business communications solutions for the IT industry in the United States. The company's convergence servers and software application solutions offer advanced voice, video, and data communications platforms and applications for quality assurance and management, event notification and alerting, recording and monitoring, and collaborative solutions. It also provides Cistera 1.9 software platform, a component-based architecture that enables enhanced scalability and management of advanced unified communications applications; and Quality Assurance and Management systems that allow organizations to respond to the needs of their customers and their partners, as well as enable organizations to build feedback loops by automating audit and compliance needs through recording and monitoring systems. In addition, the company offers Event Alerting and Notification solutions for the delivery of timely and actionable information for organizations of various sizes. Further, it provides support and maintenance, and professional services. The company was formerly known as CNH Holdings Company and changed its name to Cistera Networks Inc in September 2005. Cistera Networks, Inc. was founded in 1987 and is headquartered in Plano, Texas.
Full CNWT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.